TIENGO, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 8.070
AS - Asia 977
EU - Europa 824
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
AF - Africa 1
SA - Sud America 1
Totale 9.879
Nazione #
US - Stati Uniti d'America 8.067
CN - Cina 515
SG - Singapore 281
FI - Finlandia 191
SE - Svezia 181
VN - Vietnam 155
DE - Germania 124
UA - Ucraina 99
FR - Francia 97
GB - Regno Unito 71
IT - Italia 39
IN - India 15
IE - Irlanda 11
NL - Olanda 5
HK - Hong Kong 4
CA - Canada 3
EU - Europa 3
KR - Corea 3
BE - Belgio 2
IR - Iran 2
NZ - Nuova Zelanda 2
PL - Polonia 2
AM - Armenia 1
AU - Australia 1
BG - Bulgaria 1
EG - Egitto 1
JP - Giappone 1
NO - Norvegia 1
PE - Perù 1
Totale 9.879
Città #
Fairfield 1.323
Woodbridge 783
Chandler 670
Houston 634
Jacksonville 583
Ann Arbor 483
Wilmington 482
Ashburn 477
Seattle 471
Cambridge 459
Singapore 218
Princeton 201
Boardman 181
Dong Ket 155
Roxbury 123
San Diego 123
Beijing 114
Santa Clara 98
Nanjing 93
Guangzhou 66
Helsinki 65
Des Moines 64
Medford 62
Shenyang 34
Hebei 30
Shanghai 27
Nanchang 26
Norwalk 26
Jiaxing 20
Changsha 15
New York 13
Dublin 11
Tianjin 11
Redwood City 10
London 8
Padova 8
Dearborn 7
Ogden 7
Hefei 6
Jinan 6
Borås 5
Kharkiv 5
Rome 5
Tappahannock 5
Hong Kong 4
Kilburn 4
Chiswick 3
Dallas 3
Hounslow 3
Indiana 3
Los Angeles 3
Milan 3
Rockville 3
Washington 3
Ardabil 2
Boulder 2
Chicago 2
Frankfurt am Main 2
Fuzhou 2
Gallio 2
Groningen 2
Kent 2
New Bedfont 2
Ningbo 2
Palermo 2
Paris 2
Prescot 2
Pune 2
San Francisco 2
Wandsworth 2
Auckland 1
Augusta 1
Barnet 1
Bologna 1
Brentford 1
Brussels 1
Catania 1
Edmonton 1
Falls Church 1
Freiburg 1
Gouvieux 1
Hangzhou 1
Hendon 1
Huzhou 1
Islington 1
Jinhua 1
Kunming 1
Lanzhou 1
Lima 1
Manchester 1
Mons 1
Munich 1
Nanning 1
Nuremberg 1
Okotoks 1
Pinehaven 1
Prineville 1
Seoul 1
Shaoxing 1
Shenzhen 1
Totale 8.307
Nome #
EFFECTS OF CHRONIC ALCOHOL INTAKE ON CARBOHYDRATE AND LIPID-METABOLISM IN SUBJECTS WITH TYPE-II (NON-INSULIN-DEPENDENT) DIABETES 147
Closed-Loop Artificial Pancreas Using Subcutaneous Glucose Sensing and Insulin Delivery and a Model Predictive Control Algorithm: Preliminary Studies in Padova and Montpellier 138
A stepwise approach to assess the impact of clustering cardiometabolic risk factors on carotid intima-media thickness: the metabolic syndrome no-more-than-additive. 133
Microangiopathy is independently associated with presence, severity and composition of carotid atherosclerosis in type 2 diabetes. 128
Number and function of endothelial progenitor cells as a marker of severity of diabetic vasculopathy. 124
Circulating Endothelial Progenitor Cells Are Reduced In Peripheral Vascular Complications of Type 2 Diabetes Mellitus 123
Diabetes induces p66(shc) gene expression in human peripheral blood mononuclear cells: Relationship to oxidative stress 122
Circulating CD34(+) cells, metabolic syndrome, and cardiovascular risk 118
Brain function rescue effect of lactate following hypoglycaemia is not an adaptation process in both normal and Type I diabetic subjects 116
Endothelial progenitor cells and the diabetic paradox. 113
Mechanisms of acute and chronic hypoglycemic action of gliclazide 113
Cerebrovascular disease in diabetes mellitus: the role of carotid intima-media thickness. 111
Arterio-venous gradient of endothelial progenitor cells across renal artery stenosis. 111
Peripheral blood CD34(+)KDR(+) endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population 111
Optimized glycaemic control achieved with add-on basal insulin therapy improves indexes of endothelial damage and regeneration in type 2 diabetic patients with macroangiopathy: a randomized crossover trial comparing detemir versus glargine. 108
Albumin and fibrinogen synthesis and insulin effect in type 2 diabetic patients with normoalbuminuria. 108
Acute alcohol consumption improves insulin action without affecting insulin secretion in type 2 diabetic subjects 107
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 107
Two cases of statin-induced rhabdomyolysis associated with mononeuropathy. 105
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 105
A 2026 D peptide as the putative pancreatic cancer-associated diabetogenic factor 103
Abnormal cytoskeletal protein expression in cultured skin fibroblasts form type 1 diabetes mellitus patiens with nephropathy: A proteomic approach. 103
Postprandial myocardial perfusion in healthy subjects and in type 2 diabetic patients 102
Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes. 101
Metformin treatment of rats with diet-induced overweight and hypertriglyceridemia decreases plasma triglyceride concentrations, while decreasing triglyceride and increasing ketone body output by the isolated perfused liver 101
Hyperaminoacidaemia reduces insulin-mediated glucose disposal in healthy man. 97
The use of degrees of certainty to evaluate knowledge 96
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 96
Hepatic lipid metabolism and non-alcoholic fatty liver disease. 94
Insulin generates free radicals in human fibroblasts ex vivo by a protein kinase C-dependent mechanism, which is inhibited by pravastatin 93
Non esterified fatty acids and endothelial dysfunction 93
Carbohydrate and lipid metabolism in cirrhosis. Evidence that hepatic uptake of gluconeogenic precursors and of free fatty acids depends on effective hepatic flow. 93
The metabolic syndrome, diabetes and lung dysfunction. 93
Low CD34+ cell count and metabolic syndrome synergistically increase the risk of adverse outcomes. 93
Effects of treatment with sulfonylurea drugs or insulin on ischemia-induced myocardial dysfunction in type 2 diabetes 91
Continuous subcutaneous insulin infusion (CSII) in Italy 90
Gemfibrozil improves insulin sensitivity and flow-mediated vasodilatation in type 2 diabetic patients 89
Regulation of postprandial whole-body proteolysis in insulin-deprived IDDM. 89
Effects of insulin treatment on ketone body production and carnitine-palmitoyl-transferase (CPT) activity in the isolated perfused liver from streptozotocin diabetic rats. 88
Prevalence of microangiopathic complications in hyperglycemia secondary to pancreatic disease. 88
The effect of continuous subcutaneous insulin infusion treatment on proliferative diabetic retinopathy. 88
Glucose metabolic alterations in isolated and perfused rat hepatocytes induced by pancreatic cancer conditioned medium: A low molecular weight factor possibly involved 88
The effects of different plasma insulin concentrations on lipolytic and ketogenic responses to epinephrine in normal and Type 1 (insulin-dependent) diabetic humans 88
Insulin-mediated glucose disposal in type I diabetes: evidence for insulin resistance. 88
Continuous subcutaneous glucose monitoring in diabetic patients - A multicenter analysis 87
Effects of different plasma glucose concentrations on lipolytic and ketogenic responsiveness to epinephrine in type I (insulin-dependent) diabetic subjects 87
Characteristics and mortality of type 2 diabetic patients hospitalized for severe iatrogenic hypoglycemia 87
Relationship between plasma leucine concentration and clearance in normal and type 1 diabetic subjects. 86
Effects of oral amino acid supplementation on myocardial function in patients with type 2 diabetes mellitus 86
The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha. 86
Hyperalaninaemia is an early feature of diabetes secondary to total pancreatectomy. 86
Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes 86
Diabetic ketosis activates lymphomonocyte-inducible nitric oxide synthase. 86
Early myocardial dysfunction in the diabetic heart: Current research and clinical applications 84
Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus 82
Glucose tolerance during moderate alcohol intake: Insights on insulin action from glucose/lactate dynamics 82
Continuous subcutaneous insulin infusion (CSII) in the Veneto region: efficacy, acceptability and quality of life. 82
Effect of acute ketosis on the endothelial function of type 1 diabetic patients: the role of nitric oxide. 80
Sequelae of acute hypoglycaemia on 24 hour blood pressure and metabolic parameters in normal and type 1 (insulin-dependent) diabetic individuals. 80
Role of anti-granulocyte Fab ' fragment antibody scintigraphy (LeukoScan) in evaluating bone infection: acquisition protocol, interpretation criteria and clinical results 80
First isolation of Burkholderia cepacia from a deep neck abscess in a diabetic patient successfully treated with hyperbaric oxygen. 80
Dose-response curves of effects of insulin on leucine kinetics in humans. 80
Effects of metformin treatment on whole-body and splanchnic amino acid turnover in mild type 2 diabetes. 79
Educating diabetic patients about insulin use: changes over time in certainty and correctness of knowledge. 79
Insulin infusion normalizes fasting and postprandial albumin and fibrinogen synthesis in type 1 diabetes mellitus 79
Glucose tolerance is negatively associated with circulating progenitor cell levels. 78
Plasma free fatty acids and endothelium-dependent vasodilation: effect of chain-length and cyclooxygenase inhibition 77
Ketone body metabolism in NIDDM. Effect of sulfonylurea treatment 77
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 77
Characteristics and outcomes of the hyperglycemic hyperosmolar non-ketotic syndrome in a cohort of 51 consecutive cases at a single center. 77
Left ventricular mass in type 2 diabetes mellitus. A study employing a simple ECG index: The Cornell voltage 76
In situ protein Kinase C activity is increased in cultured fibroblasts from Type 1 diabetic patients with nephropathy 75
The effects of oral amino acid intake on ambulatory capacity in elderly subjects 75
The metabolic syndrome, diabetes and lungdysfunction. 75
Effect of different times of administration of a single ethanol dose on insulin action, insulin secretion and redox state. 75
Model of the kinetics of ketone bodies in humans. 75
Increased fibrinogen production in type 2 diabetic patients without detectable vascular complications: Correlation with plasma glucagon concentrations 75
Metabolic effects of moderate alcohol intake with meals in insulin-dependent diabetics controlled by artificial endocrine pancreas (AEP) and in normal subjects. 74
Effect of insulin replacement on intermediary metabolism in diabetes secondary to pancreatectomy. 74
Ketone body metabolism in normal and diabetic human skeletal muscle. 72
Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients 71
Mechanisms of fasting hypoglycemia and concomitant insulin resistance in insulinoma patients 70
Forearm ketone body metabolism in normal and in insulin-dependent diabetic patients. 70
High blood ketone body concentration in type 2 non-insulin dependent diabetic patients. 70
Elevated non-esterified fatty acids impair nitric oxide independent vasodilation, in humans: evidence for a role of inwardly rectifying potassium channels. 70
In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine 70
Circulating progenitor cells in the natural history of type 2 diabetes mellitus 69
Role of intra-arterial calcium injection test and venous sampling (IACI) as localizing procedure in insulinomas. 68
Alcohol impairs insulin sensitivity in normal subjects. 68
PROTEIN METABOLISM IN GLUCAGONOMA. 67
Effect of streptozotocin in a case of glucagon-secreting malignant islets-cell tumor. 66
Extreme but asymptomatic hypergastrinemia with gastroparesis in a young woman with insulin dependent diabetes mellitus. 65
Characteristics and mortality oftype 2 diabetic patients hospitalized for severe iatrogenic hypoglycemia. 63
Continuous glucose monitoring in conditions other than diabetes 63
Accuracy of continuous subcutaneous glucose monitoring in detecting hypoglycemia in diabetic patients 62
Visceral obesity is characterized by impaired nitric oxide-independent vasodilation 61
A post-hypoglycaemic increase of lactate can rescue cognitive function and counterregulatory responses to hypoglycaemia 60
INTRA-ARTERIAL CALCIUM INJECTION TEST AS LOCALIZING PROCEDURE IN INSULINOMAS. 59
Surgical removal of insulinoma restores glucose recovery from hypoglycaemia but does not normalize insulin action. 59
Enhanced responsiveness of blood pressure to sodium intake and to angiotensin II is associated with insulin resistance in IDDM patients with microalbuminuria 59
Totale 8.779
Categoria #
all - tutte 33.796
article - articoli 30.193
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 498
Totale 64.487


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.519 0 0 0 0 216 178 213 242 209 200 131 130
2020/20211.551 65 130 23 135 87 164 39 142 230 118 186 232
2021/20221.633 23 191 219 109 64 120 74 162 98 25 200 348
2022/20231.319 248 142 9 179 206 174 1 110 171 7 57 15
2023/2024503 18 87 56 38 30 32 16 9 16 80 52 69
2024/2025680 6 182 136 84 272 0 0 0 0 0 0 0
Totale 9.884